Mundus Pharmaceuticals Private Limited
About Mundus Pharmaceuticals Private Limited
Data last updated:
Mundus Pharmaceuticals Private Limited is a private limited company based in Lucknow, Uttar Pradesh, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 06 March 2014 and has been in existence for over 12 years.
The company is registered with the Registrar of Companies (ROC), Kanpur, under CIN U33110UP2014PTC063143. Its GSTIN is 09AAJCM1839K1Z1 (Uttar Pradesh).
The company has an authorised share capital of ₹5 Lakh and a paid-up capital of ₹5 Lakh. It is led by directors Rajiv Kumar Sinha and Rajni Sinha.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at Flat No. 101 – A Prathvi Sadan 1 Wala Qadar Road Near Qaiserbagh, Lucknow, Uttar Pradesh, India – 226001.
As per the financials filed for FY 2024, the company reported a revenue of ₹21.58 Lakh, a decline of 11% compared to the previous year. For the same year it recorded a net profit of ₹97,217 (net margin 4.5%) and EBITDA of ₹2.07 Lakh (EBITDA margin 9.6%). Revenue has grown at a compounded annual rate (CAGR) of 54% over three years and 24% over five years.
As per MCA filings, the company has open charges of ₹10 Lakh on record.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Mundus Pharmaceuticals Private Limited's registered office is in Lucknow, Uttar Pradesh. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressFlat No. 101 – A Prathvi Sadan 1 Wala Qadar Road Near Qaiserbagh, Lucknow, Uttar Pradesh, India – 226001
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Mundus Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Mundus Pharmaceuticals is trade. In detail, this covers wholesale trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G1 | Wholesale Trading |
To see the full business activity and turnover split of Mundus Pharmaceuticals Private Limited, buy the company report.
Financials of Mundus Pharmaceuticals Private Limited
FY 2025 filings availableMundus Pharmaceuticals Private Limited reported revenue of ₹21.58 Lakh (down 11% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue fell 11% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 24%. EBITDA rose 73% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹2.07 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹97,217 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 9.6% | ||||
| Net Profit Margin | 4.5% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Mundus Pharmaceuticals Private Limited, buy the company report.
Board of directors of Mundus Pharmaceuticals Private Limited
Mundus Pharmaceuticals has 2 current directors and 3 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Rajiv Kumar Sinha | Director | 18 Sep 2017 | 9 Years 1 Months | Current |
| Rajni Sinha | Director | 06 Mar 2014 | 12 Years 8 Months | Current |
Auditor
Mundus Pharmaceuticals Private Limited is audited by Dhawan Pandey & Associates for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Dhawan Pandey & Associates | FY 2017 | FRN013617C |
Shareholding
The shareholding of Mundus Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Mundus Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 15 Mar 2020 | 100336981 | Others | ₹10 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Mundus Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Mundus Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Mundus Pharmaceuticals has 1 GST registration: 1 active.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 09AAJCM1839K1Z1 | Uttar Pradesh | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Mundus Pharmaceuticals Private Limited, buy the company report.
Recent activity
Mundus Pharmaceuticals Private Limited has 5 board changes on record since 2014: 2 appointments and 3 cessations. The latest: Nishi Sinha ceased to be Director on 31 Jan 2024.
Frequently asked questions
Mundus Pharmaceuticals is an active private limited company based in Lucknow, Uttar Pradesh, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 06 March 2014 (12+ years old) and is registered under CIN U33110UP2014PTC063143.
Mundus Pharmaceuticals has 2 current directors:
- Rajiv Kumar Sinha - Director
- Rajni Sinha - Director
The latest financial statements of Mundus Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Mundus Pharmaceuticals is 09AAJCM1839K1Z1, registered in Uttar Pradesh.
The CIN (Corporate Identification Number) of Mundus Pharmaceuticals is U33110UP2014PTC063143. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Mundus Pharmaceuticals was incorporated on 06 March 2014, making it 12+ years old. It is registered with the Registrar of Companies, Kanpur.
Nishi Sinha ceased to be Director on 31 Jan 2024. Sanjeev Kumar ceased to be Director on 31 Jan 2024. Rajiv Kumar Sinha ceased to be Additional Director on 30 Sep 2017. Mundus Pharmaceuticals has 5 board changes on record in total.
The registered office of Mundus Pharmaceuticals is at Flat No. 101 – A Prathvi Sadan 1 Wala Qadar Road Near Qaiserbagh, Lucknow, Uttar Pradesh, India – 226001.
Mundus Pharmaceuticals operates in the pharma industry, in the drug formulation and development segment.
Mundus Pharmaceuticals has open charges of ₹10 Lakh and no satisfied charges on record as per latest MCA filings.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
